Cardiopulmonary bypass-associated acute kidney injury: A pigment nephropathy?

Contributions to Nephrology

Volumn 156, Issue , 2007, Pages 340-353

  Haase, Michael ^a,b   Haase Fielitz, Anja ^a,b   Bagshaw, Sean M ^a   Ronco, Claudio ^c   Bellomo, Rinaldo ^a,d  

^a AUSTIN HEALTH   (Australia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c SAN BORTOLO HOSPITAL   (Italy)

^d AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; HEMOGLOBIN; REACTIVE OXYGEN METABOLITE;

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOPULMONARY BYPASS; ECONOMICS; HEALTH CARE COST; HEMOGLOBINURIA; HUMAN; KIDNEY CORTEX NECROSIS; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR;

CARDIOPULMONARY BYPASS; HEALTH CARE COSTS; HEMOGLOBINS; HEMOGLOBINURIA; HUMANS; KIDNEY CORTEX NECROSIS; KIDNEY FAILURE, ACUTE; REACTIVE OXYGEN SPECIES; RISK FACTORS; SODIUM BICARBONATE;

EID: 34247605137     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102125     Document Type: Article

References (89)

1. Albert MA, Antman EM: Preoperative evaluation for cardiac surgery; in Cohn LH, Edmunds LH Jr (eds): Cardiac Surgery in the Adult. New York, McGraw-Hill, 2003, pp 235-248.
2. Chertow GM, Levy EM, Hammermeister KE, et al: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-348.
3. Loef BG, Epema AH, Smilde TD, et al: Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005;16:195-200.
4. Conlon PJ, Stafford-Smith M, White WD, et al: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999;14:1158-1162.
5. Stafford-Smith M, Podgoreanu M, Swaminathan M, et al: Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005;45:519-530.
6. Bove T, Landoni G, Calabro MG, et al: Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005;111:3230-3235.
7. Thakar CV, Arrigain S, Worley S, et al: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005;16:162-168.
8. Boldt J, Brenner T, Lehmann A, et al: Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 2003;75:906-912.
9. Fischer UM, Weissenberger WK, Warters RD, et al: Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 2002;17:401-406.
10. Landoni G, Zangrillo A, Franco A, et al: Long-term outcome of patients who require renal replacement therapy after cardiac surgery. Eur J Anaesthesiol 2006;23:17-22.
11. Fischer MJ, Brimhall BB, Lezotte DC, et al: Uncomplicated acute renal failure and hospital resource utilization: a retrospective multicenter analysis. Am J Kidney Dis 2005;46:1049-1057.
12. Mangano CM, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
13. Antunes PE, Prieto D, Ferrao de Oliveira J, Antunes MJ: Renal dysfunction after myocardial revascularization. Eur J Cardiothorac Surg 2004;25:597-604.
14. Lassnigg A, Schmidlin D, Mouhieddine M, et al: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-1605.
15. Zanardo G, Michielon P, Paccagnella A, et al: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994;107:1489-1495.
16. Starkopf J, Zilmer K, Vihalemm T, et al: Time course of oxidative stress during open-heart surgery. Scand J Thorac Cardiovasc Surg 1995;29:181-186.
17. McColl AJ, Keeble T, Hadjinikolaou L, et al: Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 1998;35:616-623.
18. Doi K, Suzuki Y, Nakao A, et al: Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 2004;65:1714-1723.
19. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
20. Urzua J, Troncoso S, Bugedo G, et al: Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 1992;6:299-303.
21. Butler J, Emerman C, Peacock WF, et al: The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Nephrol Dial Transplant 2004;19:391-399.
22. Wang DJ, Dowling TC, Meadows D, et al: Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 2004;110:1620-1625.
23. Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005;111:1487-1491.
24. Boldt J, Brosch C, Piper SN, et al: Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 2001;29:952-958.
25. Colson P, Ribstein J, Mimran A, et al: Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 1990;72:23-27.
26. Ryckwaert F, Colson P, Ribstein J, et al: Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 2001;86:169-175.
27. Lassnigg A, Donner E, Grubhofer G, et al: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
28. Sirivella S, Gielchinsky I, Parsonnet V: Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000;69:501-506.
29. Burns KE, Chu MW, Novick RJ, et al: Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA 2005;294:342-350.
30. Sward K, Valsson F, Odencrants P, et al: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004;32:1310-1315.
31. Mentzer RM Jr, Oz MC, Sladen RN, et al: Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. J Am Coll Cardiol 2007;49:716-726.
32. Brezis M, Rosen S: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995;332:647-655.
33. Bhat JG, Gluck MC, Lowenstein J, Baldwin DS: Renal failure after open heart surgery. Ann Intern Med 1976;84:677-682.
34. Abel RM, Buckley MJ, Austen WG, et al: Acute postoperative renal failure in cardiac surgical patients. J Surg Res 1976;20:341-348.
35. Rosenberger C, Rosen S, Heyman SN: Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006;33:980-988.
36. Gladwin MT, Crawford JH, Patel RP: The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 2004;36:707-717.
37. Andersson LG, Bratteby LE, Ekroth R, et al: Renal function during cardiopulmonary bypass: influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 1994;8:597-602.
38. Abbott WM, Austen WG: The reversal of renal cortical ischemia during aortic occlusion by mannitol. J Surg Res 1974;16:482-489.
39. Dada LA, Chandel NS, Ridge KM, et al: Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 2003;111:1057-1064.
40. Habib RH, Zacharias A, Schwann TA, et al: Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005;33:1749-1756.
41. Chello M, Mastroroberto P, Patti G, et al: Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 2003;89:538-543.
42. Boyle EM Jr, Lille ST, Allaire E, et al: Endothelial cell injury in cardiovascular surgery: atherosclerosis. Ann Thorac Surg 1997;63:885-894.
43. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-244.
44. Partrick DA, Moore EE, Fullerton DA, et al: Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 1999;86:42-49.
45. Nath KA, Norby SM: Reactive oxygen species and acute renal failure. Am J Med 2000;109:665-678.
46. Cunningham PN, Dyanov HM, Park P, et al: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002;168:5817-5823.
47. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000;11:152-176.
48. Heyman SN, Rosen S, Darmon D, et al: Endotoxin-induced renal failure. II. A role for tubular hypoxic damage. Exp Nephrol 2000;8:275-282.
49. Sucu N, Cinel I, Unlu A, et al: N-Acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 2004;34:237-242.
50. Ristikankare A, Kuitunen T, Kuitunen A, et al: Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006;97:611-616.
51. Hynninen MS, Niemi TT, Poyhia R, et al: N-Acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. Anesth Analg 2006;102:1638-1645.
52. Morariu AM, Loef BG, Aarts LP, et al: Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005;128:2677-2687.
53. Boldt J, Brosch C, Lehmann A, et al: The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004;99:1009-1017, table of contents.
54. Boldt J, Brosch C, Suttner S, et al: Prophylactic use of the phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function. Intensive Care Med 2002;28:1462-1469.
55. Evenepoel P: Acute toxic renal failure. Best Pract Res Clin Anaesthesiol 2004;18:37-52.
56. Paller MS: Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988;255:F539-F544.
57. Zager RA, Gamelin LM: Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol 1989;256:F446-F455.
58. Tam SC, Wong JT: Impairment of renal function by stroma-free hemoglobin in rats. J Lab Clin Med 1988;111:189-193.
59. Takami Y, Makinouchi K, Nakazawa T, et al: Effect of surface roughness on hemolysis in a pivot bearing supported Gyro centrifugal pump (C1E3). Artif Organs 1996;20:1155-1161.
60. Tanaka K, Kanamori Y, Sato T, et al: Administration of haptoglobin during cardiopulmonary bypass surgery. ASAIO Trans 1991;37:M482-M483.
61. Feola M, Simoni J, Tran R, Canizaro PC: Nephrotoxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 1990;18:233-249.
62. Lehotsky J, Kaplan P, Matejovicova M, et al: Ion transport systems as targets of free radicals during ischemia reperfusion injury. Gen Physiol Biophys 2002;21:31-37.
63. Halliwell B, Gutteridge JM: Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.
64. Atkins JL: Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron 1986;44:70-74.
65. Keene WR, Jandl JH: The sites of hemoglobin catabolism. Blood 1965;26:705-719.
66. Loebl EC, Baxter CR, Curreri PW: The mechanism of erythrocyte destruction in the early post-burn period. Ann Surg 1973;178:681-686.
67. Kanamori Y, Tanabe H, Shimono T, et al: The effects of administration of haptoglobin for hemolysis by extracorporeal circulation (in Japanese). Rinsho Kyobu Geka 1989;9:463-467.
68. Clyne DH, Kant KS, Pesce AJ, Pollak VE: Nephrotoxicity of low molecular weight serum proteins: physicochemical interactions between myoglobin, hemoglobin, bence-jones proteins and tamm-horsfall mucoprotein. Curr Probl Clin Biochem 1979;9:299-308.
69. Loef BG, Epema AH, Navis G, et al: Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. Chest 2002;121:1190-1194.
70. Tamari Y, Lee-Sensiba K, Leonard EF, et al: The effects of pressure and flow on hemolysis caused by Bio-Medicus centrifugal pumps and roller pumps. Guidelines for choosing a blood pump. J Thorac Cardiovasc Surg 1993;106:997-1007.
71. Crane KA, Brown D, Anderson R, Begelman KM: Further decrease in subclinical hemolysis utilizing 12.7 mm tubing in the arterial roller head. Ann Thorac Surg 1983;35:463-465.
72. Skrabal CA, Khosravi A, Westphal B, et al: Effects of poly-2-methoxyethylacrylate (PMEA)-coating on CPB circuits. Scand Cardiovasc J 2006;40:224-229.
73. Yamaguchi H, Shimizu T, Akutsu H, et al: Hemolysis and red cell deformability during cardiopulmonary bypass - the effect of prostaglandin E1 for prevention of hemolysis (in Japanese). Nippon Kyobu Geka Gakkai Zasshi 1990;38:625-629.
74. Hirayama T, Herlitz H, Jonsson O, Roberts D: Deformability and electrolyte changes of erythrocytes in connection with open heart surgery. Scand J Thorac Cardiovasc Surg 1986;20:253-259.
75. Azemoto R, Tsuchiya Y, Ai T, et al: Does gallstone formation after open cardiac surgery result only from latent hemolysis by replaced valves? Am J Gastroenterol 1996;91:2185-2189.
76. Ai T, Azemoto R, Saisho H: Prevention of gallstones by ursodeoxycholic acid after cardiac surgery. J Gastroenterol 2003;38:1071-1076.
77. Jaenike JR: The renal lesion associated with hemoglobinemia: a study of the pathogenesis of the excretory defect in the rat. J Clin Invest 1967;46:378-387.
78. Das DK, Engelman RM, Liu X, et al: Oxygen-derived free radicals and hemolysis during open heart surgery. Mol Cell Biochem 1992;111:77-86.
79. Gutteridge JM: Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986;201:291-295.
80. Halliwell B, Gutteridge JM: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
81. Cohen G: The Fenton reaction; in Greenwald RA (ed): CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, CRC Press, 1985, pp 55-64.
82. Ohshiro T, Kosaki G, Funakoshi S: Haptoglobin therapy: effect on prevention and treatment of hemoglobinuria. Med J Osaka Univ 1978;29:269-279.
83. Ohshiro TU, Mukai K, Kosaki G: Prevention of hemoglobinuria by administration of haptoglobin. Res Exp Med (Berl) 1980;177:1-12.
84. Yoshioka T, Sugimoto T, Ukai T, Oshiro T: Haptoglobin therapy for possible prevention of renal failure following thermal injury: a clinical study. J Trauma 1985;25:281-287.
85. Shah SV, Walker PD: Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 1988;255:F438-F443.
86. Caulfield JL, Singh SP, Wishnok JS, et al: Bicarbonate inhibits N-nitrosation in oxygenated nitric oxide solutions. J Biol Chem 1996;271:25859-25863.
87. Merten GJ, Burgess WP, Gray LV, et al: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-2334.
88. Bakris GL, Lass N, Gaber AO, et al: Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990;258:F115-F120.
89. Katholi RE, Woods WT Jr, Taylor GJ: Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998;32:64-71.